首页> 外文期刊>In vivo. >A Multiplex PCR for Non-invasive Fetal RHD Genotyping Using Cell-free Fetal DNA
【24h】

A Multiplex PCR for Non-invasive Fetal RHD Genotyping Using Cell-free Fetal DNA

机译:使用无细胞胎儿DNA进行非侵入性胎儿RHD基因分型的多重PCR

获取原文
           

摘要

Aim: To design a protocol for non-invasive prenatal diagnosis of fetal Rhesus D (RhD) status. Materials and Methods: A total of 112 single lymphocytes were used to test the efficiency of the assay. The protocol was validated using blood samples from 84 RhD-negative pregnant women at 7-24 weeks of gestation. Cell-free DNA (cfDNA) was enzymatically digested using AciI and analyzed by a polymerase chain reaction (PCR) that allowed simultaneous amplification of RHD exons 7 and 10, SRY, RASFF1A and ACTB. Results: On the one genome-equivalent level, the efficiency of the protocol was [≥]94.6% for each locus amplified. Conclusive results from the first set of PCRs were obtained for 79 cases with one false-positive. In five cases the analysis was repeated and, subsequently, all cases were accurately diagnosed. Conclusion: The proposed protocol is rapid, applicable in most molecular diagnostic laboratories and provides the basis for non-invasive examination of fetal RhD with 96.7% specificity and 100% sensitivity
机译:目的:设计一种用于胎儿恒河猴D(RhD)状态的非侵入性产前诊断的方案。材料和方法:总共112个单淋巴细胞用于测试测定的效率。妊娠7-24周时使用84名RhD阴性孕妇的血液样本对方案进行了验证。使用AciI对无细胞DNA(cfDNA)进行酶消化,并通过聚合酶链反应(PCR)进行分析,该聚合酶链反应可同时扩增RHD外显子7和10,SRY,RASFF1A和ACTB。结果:在一个基因组当量的水平上,每个扩增基因座的操作效率为[≥] 94.6%。从第一组PCR获得的结论性结果为79例假阳性患者。在五种情况下,重复分析,随后,所有病例均被准确诊断。结论:所提出的方案是快速的,适用于大多数分子诊断实验室,并为胎儿RhD的无创检查提供了基础,特异性为96.7%,灵敏度为100%

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号